Critical Business Issues and Strategies for ASCs Resulting From COVID-19

The Coronavirus (COVID-19) pandemic continues to cause substantial disruption to the ambulatory surgery center (ASC) industry. The path back to normalcy is uncertain, as we wait to see how long the pandemic and its effects will last. On the positive side, there are now discussions of a state-by-state phased plan to start re-opening the economy. We understand that the first phase in most states includes allowing elective outpatient surgical procedures to resume.

The timing is ripe to hear from experienced ASC CEOs who will share their successful COVID-19 strategies, as well as their vision and plans for the future. In this in-depth virtual conference, we will also address ASC M&A activity, which has been at a practical standstill, and map out strategies and the vision of ASC M&A executives for the post-COVID-19 ASC deal market.

For inquiries, please contact Hillary Hitt.